37 results
8-K
EX-99.1
INLB
Item 9 Labs Corp.
16 May 22
Item 9 Labs Corp. Announces Second Quarter FY 2022 Financial Results with Revenue Growth of 9% to $6.6 Million
12:00am
high-quality, alternative medicine to consumers nationwide. As large equity holders, our goals remain aligned with our shareholders in creating long
DEF 14C
9pbkts
3 Feb 21
Information statement
5:16pm
PRER14C
u9axkftv ah
25 Jan 21
Preliminary revised information
12:00am
PRER14C
upv ib4wz7
23 Dec 20
Preliminary revised information
6:05am
PRER14C
5wc 7bwbdi
21 Apr 20
Preliminary revised information
12:13pm
10-12G/A
85ynl
22 Aug 19
Registration of securities (amended)
2:49pm
10-12G
399qw6 9h3
27 Jun 19
Registration of securities
12:00am
10-12G
EX-99.1
ngq03h
27 Jun 19
Registration of securities
12:00am